Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition

Journal of the American College of Cardiology

Volumn 63, Issue 14, 2014, Pages 1355-1367

  Attizzani, Guilherme F ^a,b,c   Capodanno, Davide ^a,d   Ohno, Yohei ^a   Tamburino, Corrado ^a,d  

^a UNIVERSITY OF CATANIA   (Italy)

^b Hospital Pitangueiras   (Brazil)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d Excellence Through Newest Advances ETNA Foundation   (Italy)

Author keywords

drug eluting stent(s); incomplete stent apposition; intravascular ultrasound; optical coherence tomography; percutaneous coronary intervention; stent malapposition

Indexed keywords

ACUTE CORONARY SYNDROME; BARE METAL STENT; BIORESORBABLE SCAFFOLD; CELL LOSS; CORONARY BIFURCATION LESION; DRUG ELUTING STENT; EOSINOPHIL; FIBRIN DEPOSITION; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; NITINOL STENT; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SELF EXPANDING STENT; STENT MALAPPOSITION; STENT THROMBOSIS; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; INCOMPLETE STENT APPOSITION; MEDICAL DEVICE COMPLICATION; PATHOPHYSIOLOGY; PERCUTANEOUS CORONARY INTERVENTION; STENT;

DRUG-ELUTING STENT(S); INCOMPLETE STENT APPOSITION; INTRAVASCULAR ULTRASOUND; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; STENT MALAPPOSITION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; CORONARY THROMBOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTHESIS FAILURE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SIROLIMUS; STENTS; SURVIVAL RATE; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84897988857     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.01.019     Document Type: Review

References (116)

1. H.G. Bezerra, G.F. Attizzani, and V. Sirbu et al. Optical coherence tomography versus intravascular ultrasound to evaluate coronary artery disease and percutaneous coronary intervention J Am Coll Cardiol Intv 6 2013 228 236
2. M. Takano, S. Inami, and I.K. Jang et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038
3. Y. Fujino, G.F. Attizzani, S. Nakamura, M.A. Costa, and H.G. Bezerra Coronary artery aneurysms after sirolimus-eluting stent implantation: multimodality imaging evaluation J Am Coll Cardiol Intv 6 2013 423 424
4. T. Kume, K. Waseda, and J. Ako et al. Intravascular ultrasound assessment of postprocedural incomplete stent apposition J Invasive Cardiol 24 2012 13 16
5. Y. Fujino, G.F. Attizzani, S. Nakamura, M.A. Costa, and H.G. Bezerra Frequency-domain optical coherence tomography assessment of stent constriction 9 months after sirolimus-eluting stent implantation in a highly calcified plaque J Am Coll Cardiol Intv 6 2013 204 205
6. N. Guo, A. Maehara, and G.S. Mintz et al. Incidence, mechanisms, predictors, and clinical impact of acute and late stent malapposition after primary intervention in patients with acute myocardial infarction: an intravascular ultrasound substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial Circulation 122 2010 1077 1084
7. J. Ako, Y. Morino, and Y. Honda et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis J Am Coll Cardiol 46 2005 1002 1005
8. V.M. Shah, G.S. Mintz, S. Apple, and N.J. Weissman Background incidence of late malapposition after bare-metal stent implantation Circulation 106 2002 1753 1755
9. F. Feres, J.R. Costa Jr., and A. Abizaid Very late thrombosis after drug-eluting stents Catheter Cardiovasc Interv 68 2006 83 88
10. G.S. Mintz, V.M. Shah, and N.J. Weissman Regional remodeling as the cause of late stent malapposition Circulation 107 2003 2660 2663
11. D.A. Siqueira, A.A. Abizaid, and R. Costa J de et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes Eur Heart J 28 2007 1304 1309
12. Y. Ozaki, M. Okumura, and T.F. Ismail et al. The fate of incomplete stent apposition with drug-eluting stents: an optical coherence tomography-based natural history study Eur Heart J 31 2010 1470 1476
13. J.L. Gutiérrez-Chico, E. Regar, and E. Nüesch et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography Circulation 124 2011 612 623
14. Y. Fujino, G.F. Attizzani, and H.G. Bezerra et al. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography J Am Coll Cardiol Intv 6 2013 1035 1045
15. J.L. Gutiérrez-Chico, J. Wykrzykowska, and E. Nüesch et al. Vascular tissue reaction to acute malapposition in human coronary arteries: sequential assessment with optical coherence tomography Circ Cardiovasc Interv 5 2012 20 29
16. M.K. Hong, G.S. Mintz, and C.W. Lee et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up Circulation 113 2006 414 419
17. D.H. Steinberg, G.S. Mintz, and L. Mandinov et al. Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies J Am Coll Cardiol Intv 3 2010 486 494
18. K. Tanabe, P.W. Serruys, and M. Degertekin et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial Circulation 111 2005 900 905
19. S. Cook, P. Eshtehardi, and B. Kalesan et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation Eur Heart J 33 2012 1334 1343
20. A.K. Hassan, S.C. Bergheanu, and T. Stijnen et al. Late stent malapposition risk is higher after drug-eluting stent compared with bare-metal stent implantation and associates with late stent thrombosis Eur Heart J 31 2010 1172 1180
21. S. Cook, P. Wenaweser, and M. Togni et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation Circulation 115 2007 2426 2434
22. G. Guagliumi, H. Ikejima, and V. Sirbu et al. Impact of drug release kinetics on vascular response to different zotarolimus-eluting stents implanted in patients with long coronary stenoses: the LongOCT study (Optical Coherence Tomography in Long Lesions) J Am Coll Cardiol Intv 4 2011 778 785
23. T. Kubo, T. Imanishi, and H. Kitabata et al. Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study J Am Coll Cardiol Img 1 2008 475 484
24. G. Guagliumi, G. Musumeci, and V. Sirbu et al. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents J Am Coll Cardiol Intv 3 2010 531 539
25. C.W. Lee, S.J. Kang, and D.W. Park et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation J Am Coll Cardiol 55 2010 1936 1942
26. G. Guagliumi, V. Sirbu, and G. Musumeci et al. Examination of the in vivo mechanisms of late drug-eluting stent thrombosis: findings from optical coherence tomography and intravascular ultrasound imaging J Am Coll Cardiol Intv 5 2012 12 20
27. F. Alfonso, J. Dutary, and M. Paulo et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis Heart 98 2012 1213 1220
28. S.J. Kang, C.W. Lee, and H. Song et al. OCT analysis in patients with very late stent thrombosis J Am Coll Cardiol Img 6 2013 695 703
29. P. Kosonen, S. Vikman, and L.O. Jensen et al. Intravascular ultrasound assessed incomplete stent apposition and stent fracture in stent thrombosis after bare metal versus drug-eluting stent treatment: the Nordic Intravascular Ultrasound Study (NIVUS) Int J Cardiol 168 2013 1010 1016
30. G. Pesarini, R. Dandale, and A. Rigamonti et al. Late and very late coronary stent thrombosis: intravascular ultrasound findings and associations with antiplatelet therapy Catheter Cardiovasc Interv 82 2013 1056 1065
31. M. Radu, E. Jørgensen, H. Kelbæk, S. Helqvist, L. Skovgaard, and K. Saunamäki Optical coherence tomography at follow-up after percutaneous coronary intervention: relationship between procedural dissections, stent strut malapposition and stent healing EuroIntervention 7 2011 353 361
32. N.G. Uren, S.P. Schwarzacher, and J.A. Metz et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry Eur Heart J 23 2002 124 132
33. F. Alfonso, A. Suárez, and D.J. Angiolillo et al. Findings of intravascular ultrasound during acute stent thrombosis Heart 90 2004 1455 1459
34. J.L. Gutiérrez-Chico, P. Jüni, and H.M. García- García et al. Long term tissue coverage of a biodegradable polylactide polymer-coated biolimus-eluting stent: comparative sequential assessment with optical coherence tomography until complete resorption of the polymer Am Heart J 162 2011 922 931
35. G.F. Attizzani, H.G. Bezerra, and J. Ormiston et al. Serial assessment by optical coherence tomography of early and late vascular responses after implantation of an absorbable-coating sirolimus-eluting stent (from the first-in-human DESSOLVE I trial) Am J Cardiol 112 2013 1557-6.
36. J. Tanigawa, P. Barlis, K. Dimopoulos, M. Dalby, P. Moore, and C. Di Mario The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
37. R. Virmani, G. Guagliumi, and A. Farb et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
38. M. Joner, A.V. Finn, and A. Farb et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk J Am Coll Cardiol 48 2006 193 202
39. S. Cook, E. Ladich, and G. Nakazawa et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis Circulation 120 2009 391 399
40. G.F. Attizzani, H.G. Bezerra, and D. Chamié et al. Serial evaluation of vascular response after implantation of a new sirolimus-eluting stent with bioabsorbable polymer (MISTENT): an optical coherence tomography and histopathological study J Invasive Cardiol 24 2012 560 568
41. C. Templin, M. Meyer, and M.F. Müller et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy Eur Heart J 31 2010 1792 1801
42. C. Malle, T. Tada, and K. Steigerwald et al. Tissue characterization after drug-eluting stent implantation using optical coherence tomography Arterioscler Thromb Vasc Biol 33 2013 1376 1383
43. G. Nakazawa, A.V. Finn, M. Vorpahl, E.R. Ladich, F.D. Kolodgie, and R. Virmani Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus- and paclitaxel-eluting stents J Am Coll Cardiol 57 2011 390 398
44. M. Radu, E. Jørgensen, H. Kelbaek, S. Helqvist, L. Skovgaard, and K. Saunamäki Strut apposition after coronary stent implantation visualised with optical coherence tomography EuroIntervention 6 2010 86 93
45. A. Maehara, G. Mintz, and N. Weissman Advances in intravascular imaging Circ Cardiovasc Interv 2 2009 482 490
46. G.S. Mintz What to do about late incomplete stent apposition? Circulation 115 2007 2379 2381
47. H.G. Bezerra, M.A. Costa, G. Guagliumi, A.M. Rollins, and D.I. Simon Intracoronary optical coherence tomography: a comprehensive review J Am Coll Cardiol Intv 2 2009 1035 1046
48. Y. Fujino, H.G. Bezerra, and G.F. Attizzani et al. Frequency-domain optical coherence tomography assessment of unprotected left main coronary artery disease-a comparison with intravascular ultrasound Catheter Cardiovasc Interv 82 2013 E173 E183
49. E.A. Mehanna, G.F. Attizzani, H. Kyono, M. Hake, and H.G. Bezerra Assessment of coronary stent by optical coherence tomography, methodology and definitions Int J Cardiovasc Imaging 27 2011 259 269
50. F. Prati, G. Guagliumi, and G.S. Mintz et al. Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures Eur Heart J 33 2012 2513 2520
51. P. Moore, P. Barlis, and J. Spiro et al. A randomized optical coherence tomography study of coronary stent strut coverage and luminal protrusion with rapamycin-eluting stents J Am Coll Cardiol Intv 2 2009 437 444
52. B.X. Chen, F.Y. Ma, and W. Luo et al. Neointimal coverage of bare-metal and sirolimus-eluting stents evaluated with optical coherence tomography Heart 94 2008 566 570
53. J.S. Kim, I.K. Jang, and J.S. Kim et al. Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents Heart 95 2009 1907 1912
54. D. Matsumoto, J. Shite, and T. Shinke et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography Eur Heart J 28 2007 961 967
55. B.K. Kim, D.H. Shin, and J.S. Kim et al. Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation Int J Cardiovasc Imaging 28 2012 1887 1894
56. H. Kawamori, J. Shite, and T. Shinke et al. Natural consequence of post-intervention stent malapposition, thrombus, tissue prolapse, and dissection assessed by optical coherence tomography at mid-term follow-up Eur Heart J Cardiovasc Imaging 14 2013 865 875
57. A. Durán, S.K. Hian, D.L. Miller, J. Le Heron, R. Padovani, and E. Vano A summary of recommendations for occupational radiation protection in interventional cardiology Catheter Cardiovasc Interv 81 2013 562 567
58. ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) Circulation 124 2011 1250 1259
59. J.S. Kim, I.K. Jang, and C. Fan et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial J Am Coll Cardiol Intv 2 2009 1240 1247
60. S. Li, Y. Wang, and L. Gai et al. Evaluation of neointimal coverage and apposition with various drug-eluting stents over 12 months after implantation by optical coherence tomography Int J Cardiol 162 2013 166 171
61. A.V. Finn, G. Nakazawa, and M. Joner et al. Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
62. L. Räber, S. Baumgartner, and H.M. Garcia-Garcia et al. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study J Am Coll Cardiol Intv 5 2012 946 957
63. G.F. Attizzani, and H.G. Bezerra Contemporary assessment of stent strut coverage by OCT Int J Cardiovasc Imaging 29 2013 23 27
64. Y. Morino, T. Limpijankit, and Y. Honda et al. Late vascular response to repeat stenting for in-stent restenosis with and without radiation: an intravascular ultrasound volumetric analysis Circulation 105 2002 2465 2468
65. G. Guagliumi, H.G. Bezerra, and V. Sirbu et al. Serial assessment of coronary artery response to paclitaxel-eluting stents using optical coherence tomography Circ Cardiovasc Interv 5 2012 30 38
66. G. Nakazawa, A.V. Finn, and M. Joner et al. Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study Circulation 118 2008 1138 1145
67. M.K. Hong, G.S. Mintz, and C.W. Lee et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation Circulation 109 2004 881 886
68. B.L. van der Hoeven, S.S. Liem, and J. Dijkstra et al. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! Intervention study J Am Coll Cardiol Intv 1 2008 192 201
69. S.Y. Choi, B. Witzenbichler, and A. Maehara et al. Intravascular ultrasound findings of early stent thrombosis after primary percutaneous intervention in acute myocardial infarction: a Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) substudy Circ Cardiovasc Interv 4 2011 239 247
70. G. Guagliumi, M.A. Costa, and V. Sirbu et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction: optical coherence tomography substudy of the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial Circulation 123 2011 274 281
71. N. Gonzalo, P. Barlis, and P.W. Serruys et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography J Am Coll Cardiol Intv 2 2009 445 452
72. P.A. Davlouros, G. Nikokiris, and V. Karantalis et al. Neointimal coverage and stent strut apposition six months after implantation of a paclitaxel eluting stent in acute coronary syndromes: an optical coherence tomography study Int J Cardiol 151 2011 155 159
73. J.W. van Werkum, A.A. Heestermans, and A.C. Zomer et al. Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry J Am Coll Cardiol 53 2009 1399 1409
74. P. Steg, S.K. James, and D. Atar et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation Eur Heart J 33 2012 2569 2619
75. A.V. Finn, F.D. Kolodgie, and J. Harnek et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents Circulation 112 2005 270 278
76. T. Shinke, J. Li, and J.P. Chen et al. High incidence of intramural thrombus after overlapping paclitaxel-eluting stent implantation: angioscopic and histopathologic analysis in porcine coronary arteries Circ Cardiovasc Interv 1 2008 28 35
77. K. Kolandaivelu, R. Swaminathan, and W.J. Gibson et al. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings Circulation 123 2011 1400 1409
78. J. Tanigawa, P. Barlis, K. Dimopoulos, and C. Di Mario Optical coherence tomography to assess malapposition in overlapping drug-eluting stents EuroIntervention 3 2008 580 583
79. J. Aoki, G.S. Mintz, and N.J. Weissman et al. Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trials J Am Coll Cardiol Intv 1 2008 161 167
80. H. Otake, Y. Honda, and M. Yamasaki et al. Vascular response to overlapping everolimus-eluting stents: comparison with paclitaxel-eluting stents Circ J 74 2010 1023 1025
81. K.D. Dawkins, E. Grube, and G. Guagliumi et al. Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents EuroIntervention 3 2007 213 221
82. G. Guagliumi, D. Capodanno, and H. Ikejima et al. Impact of different stent alloys on human vascular response to everolimus-eluting stent: an optical coherence tomography study: the OCTEVEREST Catheter Cardiovasc Interv 81 2013 510 518
83. S. Tahara, H.G. Bezerra, and V. Sirbu et al. Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial Heart 96 2010 1574 1578
84. G. Nakazawa, S.K. Yazdani, A.V. Finn, M. Vorpahl, F.D. Kolodgie, and R. Virmani Pathological findings at bifurcation lesions: the impact of flow distribution on atherosclerosis and arterial healing after stent implantation J Am Coll Cardiol 55 2010 1679 1687
85. Y. Murasato, M. Horiuchi, and Y. Otsuji Three-dimensional modeling of double-stent techniques at the left main coronary artery bifurcation using micro-focus X-ray computed tomography Catheter Cardiovasc Interv 70 2007 211 220
86. J.A. Ormiston, E. Currie, and M.W. Webster et al. Drug-eluting stents for coronary bifurcations: insights into the crush technique Catheter Cardiovasc Interv 63 2004 332 336
87. R.A. Costa, G.S. Mintz, and S.G. Carlier et al. Bifurcation coronary lesions treated with the "crush" technique: an intravascular ultrasound analysis J Am Coll Cardiol 46 2005 599 605
88. N. Foin, E. Alegria-Barrero, and R. Torii et al. Crush, culotte, T and protrusion: which 2-stent technique for treatment of true bifurcation lesions? Insights from in vitro experiments and micro-computed tomography Circ J 77 2013 73 80
89. P. Tyczynski, G. Ferrante, and C. Moreno-Ambroj et al. Simple versus complex approaches to treating coronary bifurcation lesions: direct assessment of stent strut apposition by optical coherence tomography Rev Esp Cardiol 63 2010 904 914
90. N. Foin, R. Torii, and E. Alegria et al. Location of side branch access critically affects results in bifurcation stenting: insights from bench modeling and computational flow simulation Int J Cardiol 168 2013 3623 3628
91. E. Alegría-Barrero, N. Foin, and P.H. Chan et al. Optical coherence tomography for guidance of distal cell recrossing in bifurcation stenting: choosing the right cell matters EuroIntervention 8 2012 205 213
92. N. Foin, R. Torii, and P. Mortier et al. Kissing balloon or sequential dilation of the side branch and main vessel for provisional stenting of bifurcations: lessons from micro-computed tomography and computational simulations J Am Coll Cardiol Intv 5 2012 47 56
93. N. Foin, G.G. Secco, L. Ghilencea, R. Krams, and C. Di Mario Final proximal post-dilatation is necessary after kissing balloon in bifurcation stenting EuroIntervention 7 2011 597 604
94. S. Rahman, T. Leesar, and M. Cilingiroglu et al. Impact of kissing balloon inflation on the main vessel stent volume, area, and symmetry after side-branch dilation in patients with coronary bifurcation lesions: a serial volumetric intravascular ultrasound study J Am Coll Cardiol Intv 6 2013 923 931
95. C. Di Mario, I. Iakovou, and W.J. van der Giessen et al. Optical coherence tomography for guidance in bifurcation lesion treatment EuroIntervention 6 Suppl J 2010 J99 J106
96. Y. Fujino, G.F. Attizzani, and S. Tahara et al. Frequency-domain optical coherence tomography assessment of unfavorable kissing-balloon result in unprotected left main intervention J Am Coll Cardiol Intv 6 2013 1324 1325
97. S.J. Kang, J.M. Ahn, and H. Song et al. Comprehensive intravascular ultrasound assessment of stent area and its impact on restenosis and adverse cardiac events in 403 patients with unprotected left main disease Circ Cardiovasc Interv 4 2011 562 569
98. G. Biondi-Zoccai, I. Sheiban, and E. Romagnoli et al. Is intravascular ultrasound beneficial for percutaneous coronary intervention of bifurcation lesions? Evidence from a 4,314-patient registry Clin Res Cardiol 100 2011 1021 1028
99. M.W. Basalus, K.G. van Houwelingen, M.J. Ankone, J. Feijen, and C. von Birgelen Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents EuroIntervention 6 2010 141 148
100. T. Watanabe, M. Fujita, and M. Awata et al. Integrity of stent polymer layer after drug-eluting stent implantation: in vivo comparison of sirolimus-, paclitaxel-, zotarolimus- and everolimus-eluting stents Cardiovasc Interv Ther 29 2014 4 10
101. P. Guérin, P. Pilet, and G. Finet et al. Drug-eluting stents in bifurcations: bench study of strut deformation and coating lesions Circ Cardiovasc Interv 3 2010 120 126
102. J.P. Carrozza Jr., S.E. Hosley, D.J. Cohen, and D.S. Baim In vivo assessment of stent expansion and recoil in normal porcine coronary arteries: differential outcome by stent design Circulation 100 1999 756 760
103. N. Foin, S. Sen, and E. Allegria et al. Maximal expansion capacity with current DES platforms: a critical factor for stent selection in the treatment of left main bifurcations? EuroIntervention 8 2013 1315 1325
104. R.J. Russo, P.D. Silva, and M. Yeager Coronary artery overexpansion increases neointimal hyperplasia after stent placement in a porcine model Heart 93 2007 1609 1615
105. S. Verheye, S. Ramcharitar, and E. Grube et al. Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions EuroIntervention 7 2011 580 587
106. R.J. van Geuns, C. Tamburino, and J. Fajadet et al. Self-expanding versus balloon-expandable stents in acute myocardial infarction: results from the APPOSITION II study: self-expanding stents in ST-segment elevation myocardial infarction J Am Coll Cardiol Intv 5 2012 1209 1219
107. P. Serruys, J.A. Ormiston, and Y. Onuma et al. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods Lancet 373 2009 897 910
108. A.L. Manna, Y. Ohno, G.F. Attizzani, and C. Tamburino Successful retrograde recanalization of chronic total coronary occlusion with multiple bioresorbable vascular scaffolds ('full polymer jacket'): initial experience and rationale Eur Heart J 34 2013 2925
109. C. Grasso, G.F. Attizzani, M. Patané, Y. Ohno, D. Capodanno, and C. Tamburino First-in-human description of everolimus-eluting bioabsorbable vascular scaffold implantation for the treatment of drug-eluting stent failure: insights from optical coherence tomography Int J Cardiol 168 2013 4490 4491
110. T. Kajiya, M. Liang, and R.K. Sharma et al. Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI) EuroIntervention 9 2013 501 504
111. J. Gomez-Lara, H.M. Garcia-Garcia, and Y. Onuma et al. A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents J Am Coll Cardiol Intv 3 2010 1190 1198
112. P.W. Serruys, Y. Onuma, and D. Dudek et al. Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes J Am Coll Cardiol 58 2011 1578 1588
113. Y. Onuma, P.W. Serruys, and L.E. Perkins et al. Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine coronary artery model: an attempt to decipher the human optical coherence tomography images in the ABSORB trial Circulation 122 2010 2288 2300
114. N. Tada, R. Virmani, and G. Grant et al. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting Cypher stent in a porcine model Circ Cardiovasc Interv 3 2010 174 183
115. P. Barlis, E. Regar, and P.W. Serruys et al. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study Eur Heart J 31 2010 165 176
116. G. Guagliumi, V. Sirbu, and G. Musumeci et al. Strut coverage and vessel wall response to a new-generation paclitaxel-eluting stent with an ultrathin biodegradable abluminal polymer: Optical Coherence Tomography Drug-Eluting Stent Investigation (OCTDESI) Circ Cardiovasc Interv 3 2010 367 375